Huiqing Yu

机构：Chongqing Cancer Hospital · ORCID：0000-0002-9985-1037

发表论文 56 篇 · 总被引 607 次 · h-index 15

代表论文

• Hydrogel based flexible wearable sweat sensor for SERS-AI monitoring treatment effect of lung cancer (2024 · Sensors and Actuators B Chemical · 被引 34)
• Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study (2025 · The Lancet Respiratory Medicine · 被引 16)
• Combined early palliative care for non-small-cell lung cancer patients: a randomized controlled trial in Chongqing, China (2023 · Frontiers in Oncology · 被引 13)
• Early identification of potentially reversible cancer cachexia using explainable machine learning driven by body weight dynamics: a multicenter cohort study (2025 · American Journal of Clinical Nutrition · 被引 7)
• Mesoporous activated carbon derived from Chinese herbal medicine residues for hemoperfusion removal of uremia toxins from progressive chronic kidney diseases patients (2024 · Heliyon · 被引 6)
• Knowledge, attitudes, and current practices toward lung cancer palliative care management in China: a national survey (2024 · Frontiers in Oncology · 被引 6)